Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azelaic acid 15% formulation versus metronidazole and vehicle for papulopustular rosacea
ISRCTN10669312Phase 3Completed
- Sponsor
- Isispharma
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in papulopustular rosacea comparing Azelaic acid cream arm, Metronidazole cream arm and Vehicle cream arm (3 arms). Primary endpoints: Inflammatory lesion count at week 12, Investigator Global Assessment at week 12 and 2 more. Started Oct 2018; status: completed.
02
Drugs
Azelaic acidmetronidazole
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on ISRCTN10669312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10669312.